NOVOZYMES A/S earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-03-31 | €0.43 | €0.43 | 2026-06-19T06:02:35Z |
| 2025 | 2025-03-31 | €0.40 | €0.40 | 2026-06-19T06:02:35Z |
Revenue & profit (EUR)
| Concept | 2026 | 2025 | 2025 |
|---|---|---|---|
| Revenue | €1.12B | — | €1.08B |
| Profit for the year | €199.1M | — | €186.0M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in NOVOZYMES A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.